These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. Lee SH; Kim YS; Lee SJ; Lee BC J Ethnopharmacol; 2011 Oct; 137(3):1409-14. PubMed ID: 21856399 [TBL] [Abstract][Full Text] [Related]
3. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats]. Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713 [TBL] [Abstract][Full Text] [Related]
4. Effect of catalpol on diabetic nephropathy in rats. Dong Z; Chen CX Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of oxymatrine on experimental diabetic nephropathy. Guo C; Han F; Zhang C; Xiao W; Yang Z Planta Med; 2014 Mar; 80(4):269-76. PubMed ID: 24535719 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379 [TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350 [TBL] [Abstract][Full Text] [Related]
10. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy. Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats. Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment. Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975 [TBL] [Abstract][Full Text] [Related]
13. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993 [TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Park JH; Hwang I; Hwang SH; Han H; Ha H Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513 [TBL] [Abstract][Full Text] [Related]
15. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism. Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071 [TBL] [Abstract][Full Text] [Related]
16. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Hao HH; Shao ZM; Tang DQ; Lu Q; Chen X; Yin XX; Wu J; Chen H Life Sci; 2012 Nov; 91(19-20):959-67. PubMed ID: 23000098 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy. Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model. Elmas O; Erbas O; Yigitturk G Biomed Pharmacother; 2016 Oct; 83():392-396. PubMed ID: 27424320 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Wang S; Li Y; Zhao J; Zhang J; Huang Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166 [TBL] [Abstract][Full Text] [Related]
20. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Lai PB; Zhang L; Yang LY Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]